Savient Pharmaceuticals Inc (NASDAQ:SVNT)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar pchop123 (76.57) Submitted: 1/22/2013 2:00:11 PM : Underperform Start Price: $1.12 SVNT Score: +6.55

dismal

Featured Broker Partners


Advertisement